Rhythm Pharmaceuticals, Inc. (RYTM)
113.94
+1.66
(+1.48%)
USD |
NASDAQ |
Nov 09, 16:00
113.69
-0.25
(-0.22%)
After-Hours: 20:00
Rhythm Pharmaceuticals Total Assets (Quarterly) : 443.13M for Sept. 30, 2026
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 443.13M |
| June 30, 2026 | 437.27M |
| March 31, 2026 | 442.32M |
| December 31, 2025 | 481.19M |
| September 30, 2025 | 506.87M |
| June 30, 2025 | 372.73M |
| March 31, 2025 | 386.68M |
| December 31, 2024 | 393.47M |
| September 30, 2024 | 363.57M |
| June 30, 2024 | 381.85M |
| March 31, 2024 | 258.65M |
| December 31, 2023 | 332.74M |
| September 30, 2023 | 354.20M |
| June 30, 2023 | 309.94M |
| March 31, 2023 | 345.68M |
| December 31, 2022 | 382.48M |
| September 30, 2022 | 389.61M |
| June 30, 2022 | 277.68M |
| March 31, 2022 | 284.82M |
| December 31, 2021 | 329.52M |
| September 30, 2021 | 355.82M |
| June 30, 2021 | 388.39M |
| March 31, 2021 | 422.21M |
| December 31, 2020 | 187.07M |
| September 30, 2020 | 215.48M |
| Date | Value |
|---|---|
| June 30, 2020 | 243.48M |
| March 31, 2020 | 273.76M |
| December 31, 2019 | 308.52M |
| September 30, 2019 | 177.53M |
| June 30, 2019 | 210.89M |
| March 31, 2019 | 236.50M |
| December 31, 2018 | 260.21M |
| September 30, 2018 | 277.73M |
| June 30, 2018 | 291.75M |
| March 31, 2018 | 139.44M |
| December 31, 2017 | 151.74M |
| September 30, 2017 | 34.80M |
| June 30, 2017 | 20.40M |
| March 31, 2017 | 26.03M |
| December 31, 2016 | |
| September 30, 2016 | |
| June 30, 2016 | |
| March 31, 2016 | |
| December 31, 2015 | 37.28M |
| September 30, 2015 | |
| June 30, 2015 | |
| March 31, 2015 | |
| December 31, 2014 | 0.194M |
| September 30, 2014 | |
| June 30, 2014 | 10.69M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 7.995B |
| BioMarin Pharmaceutical, Inc. | 11.57B |
| Cytokinetics, Inc. | 1.825B |
| Exelixis, Inc. | 2.513B |
| Ionis Pharmaceuticals, Inc. | 2.913B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 241.59M |
| Shareholders Equity (Quarterly) | 201.54M |
| Debt to Equity Ratio | 0.5268 |
| Current Ratio | 2.779 |
| Net Debt Paydown Yield | 0.46% |